Eli Lilly EBIT 2010-2024 | LLY

Eli Lilly EBIT for the quarter ending December 31, 2024 was $1.887B, a 421.37% decline year-over-year.

  • Eli Lilly 2024 EBIT was 12.899B, a 99.74% increase from 2023.
  • Eli Lilly 2023 EBIT was 6.458B, a 9.39% decline from 2022.
  • Eli Lilly 2022 EBIT was 7.127B, a 12.12% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Eli Lilly EBIT 2010-2024 | LLY

  • Eli Lilly 2024 EBIT was 12.899B, a 99.74% increase from 2023.
  • Eli Lilly 2023 EBIT was 6.458B, a 9.39% decline from 2022.
  • Eli Lilly 2022 EBIT was 7.127B, a 12.12% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B